Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Peter

Showing results (11-20 of 505) with videos related to

Pageof 51
Sort By:
Investigative Ophthalmology & Visual Science|March 16, 2013
The impact of flash intensity on retinal vessel oxygen saturation measurements using dual wavelength oximetryRebekka Heitmar, Robert Peter Cubbidge
Cancer|August 6, 2019
Predicting the outcome of patients with chronic lymphocytic leukemia: Progress and uncertaintyEmili Montserrat, Robert Peter Gale
Leukemia|January 30, 2019
Is lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma?Giovanni Barosi, Robert Peter Gale
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|June 29, 2001
Biophysical measurements of human forearm skin in vivo: effects of site, gender, chirality and timeRobert Peter Chilcott, Rebecca Farrar
The Lancet. Oncology|August 8, 2018
Cancer care in the Palestinian territoriesKhalid Halahleh, Robert Peter Gale
Leukemia Research|May 20, 2009
Hypothesis: how do JAK2-inhibitors work in myelofibrosisRuben Mesa, Robert Peter Gale
Leukemia Research|February 8, 2011
Bone marrow fibrosis in myeloproliferative neoplasms-associated myelofibrosis: deconstructing a myth?Giovanni Barosi, Robert Peter Gale
Leukemia Research|August 8, 2016
Precision medicine in acute myeloid leukemia: Hope, hype or both?Vinay Prasad, Robert Peter Gale
Journal of Cancer Research and Clinical Oncology|April 18, 2016
Molecular monitoring of tyrosine kinase inhibitor therapy of chronic myeloid leukemia in ChinaQian Jiang, Robert Peter Gale
Current Hematologic Malignancy Reports|December 21, 2019
What Does Chronic Myeloid Leukaemia Tell Us About Other Leukaemias?Robert Peter Gale, Jane Apperley
Pageof 51

Showing results (11-20 of 505) with videos related to

Sort By:
Pageof 51
Investigative Ophthalmology & Visual Science|March 16, 2013
The impact of flash intensity on retinal vessel oxygen saturation measurements using dual wavelength oximetryRebekka Heitmar, Robert Peter Cubbidge
Cancer|August 6, 2019
Predicting the outcome of patients with chronic lymphocytic leukemia: Progress and uncertaintyEmili Montserrat, Robert Peter Gale
Leukemia|January 30, 2019
Is lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma?Giovanni Barosi, Robert Peter Gale
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|June 29, 2001
Biophysical measurements of human forearm skin in vivo: effects of site, gender, chirality and timeRobert Peter Chilcott, Rebecca Farrar
The Lancet. Oncology|August 8, 2018
Cancer care in the Palestinian territoriesKhalid Halahleh, Robert Peter Gale
Leukemia Research|May 20, 2009
Hypothesis: how do JAK2-inhibitors work in myelofibrosisRuben Mesa, Robert Peter Gale
Leukemia Research|February 8, 2011
Bone marrow fibrosis in myeloproliferative neoplasms-associated myelofibrosis: deconstructing a myth?Giovanni Barosi, Robert Peter Gale
Leukemia Research|August 8, 2016
Precision medicine in acute myeloid leukemia: Hope, hype or both?Vinay Prasad, Robert Peter Gale
Journal of Cancer Research and Clinical Oncology|April 18, 2016
Molecular monitoring of tyrosine kinase inhibitor therapy of chronic myeloid leukemia in ChinaQian Jiang, Robert Peter Gale
Current Hematologic Malignancy Reports|December 21, 2019
What Does Chronic Myeloid Leukaemia Tell Us About Other Leukaemias?Robert Peter Gale, Jane Apperley
Pageof 51